back to Australia directory
australia clinical guidance

Bipolar disorder: recognition, urgent risk, and shared-care monitoring

A Queensland-bounded Australian safety pathway for recognising mania or bipolar depression, assessing immediate risk and routing specialist care without implying a national medicine algorithm.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Queensland PCCM guidance is used only for acute Queensland assessment and escalation. Long-term bipolar diagnosis and treatment require specialist review plus the applicable state or territory pathway and medicine-specific TGA information.

Scope

Adults and children presenting with possible mania, hypomania, bipolar depression or relapse in primary, rural or remote care. The exact current clinical source is the Queensland PCCM mood-disorders section. Medicine-specific decisions are outside this page’s source scope and require the exact current TGA product information for the product under consideration. This is not a comprehensive national bipolar CPG and does not support a universal choice, dose or monitoring schedule for mood stabilisers or antipsychotics.
sources for this section:Queensland PCCM mood disorders

The Bottom Line

  • Establish the longitudinal episode pattern, including periods of increased energy, reduced need for sleep, pressured speech, racing thoughts, grandiosity, irritability, impulsive spending or sexual behaviour, psychosis and subsequent functional consequences.
  • Ask about substances, prescribed stimulants or antidepressants, withdrawal states, head injury, infection, endocrine or metabolic disturbance and postpartum timing because they can cause or amplify an apparent mood episode.
  • Assess suicide, self-harm, aggression, exploitation, financial or sexual risk, driving, dependent care, access to weapons and the person’s current capacity to accept safe care.
  • In the Queensland PCCM setting, consult the authorised medical or nurse-practitioner and mental-health team for immediate management, investigations, retrieval or hospital care; do not extend its Queensland authorities to another jurisdiction.
  • For any established medicine, retrieve the exact current Australian product information and the person’s monitoring record before continuation or change; a generic TGA search page is not a substitute for specialist diagnosis and a medicine-specific plan.
sources for this section:Queensland PCCM mood disorders

Practical clinical workflow

1
Stabilise physical threats and obtain observations, bedside glucose, mental-state examination, pregnancy status when relevant, medicine history and collateral description of baseline behaviour and recent change.
2
Clarify episode onset, sleep, function, psychosis, substances and adherence, and check whether an advance, relapse or perinatal plan already identifies preferred clinicians and early interventions.
3
Assess immediate risk and decide whether the person needs emergency transport, a protected low-stimulation setting, urgent specialist assessment or closely supervised community follow-up under the local law and pathway.
4
When a medicine is already prescribed, identify the exact product, last dose, recent changes, interactions and required laboratory monitoring; seek toxicology or specialist advice when toxicity or abrupt withdrawal is plausible.
5
Document the provisional diagnosis and evidence limits, communicate risk and follow-up ownership to the receiving team and arrange review of sleep, behaviour, psychosis, adverse effects and capacity after the acute episode.
sources for this section:Queensland PCCM mood disorders

Safety boundaries and escalation

  • Severe mania, a mixed state, psychosis, suicidal intent, violent behaviour, profound self-neglect or inability to provide safe dependent care requires urgent specialist or emergency assessment.
  • Fever, rigidity, reduced consciousness, seizure, severe dehydration, ataxia or marked gastrointestinal or neurological symptoms in a person taking psychotropic medicine may represent toxicity or another medical emergency.
  • Pregnancy planning, pregnancy and the postpartum period require early specialist perinatal review because both relapse and medicine exposure can carry major risks; do not make an abrupt unsupervised medicine change.
  • Do not infer a national lithium, valproate, antipsychotic or antidepressant sequence from this page; use medicine-specific TGA information and a specialist plan, including current reproductive-safety controls.
sources for this section:Queensland PCCM mood disorders

Implementation

The only comprehensive current acute source identified for this remediation is the Queensland PCCM mood-disorders section. It provides a rural and remote Queensland assessment and escalation framework, not longitudinal national bipolar guidance. Mental-health legislation, authorised practice, retrieval arrangements and crisis services differ across Australia; substitute the exact state or territory pathway and obtain psychiatrist-led treatment review.
sources for this section:Queensland PCCM mood disorders

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Queensland PCCM mood disorders

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Queensland Health and Royal Flying Doctor Service Queensland SectionPrimary Clinical Care Manual, 12th edition: Mood disorders — adult/child (depression and bipolar)ISBN 978-1-876560-22-5 · 12th edition 2025, v1.03 with updates through 21 July 2026; section 5, printed pages 343–344 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.